Summary:
The primary objective of the study is to evaluate the safety and efficacy of DS-5565 (study medication) with matching placebo in patients with Fibromyalgia for improvement in blocking pain.
Secondary objective is to evaluate the improvement of sleeping patterns in patients that have Fibromyalgia.
Qualified Participants Must:
•
Be 18 years of age or older
•
Be able to tolerate medications similar to Lyrica
•
Not have any other inflammatory disorders (i.e. Lupus, Rheumatoid Arthritis, etc.)
Qualified Participants May Receive:
Study related tests and procedures such as physical exam and ECG, Lab tests such as blood work, and compensation for time and travel expenses.